lenalidomide has been researched along with angiogenin in 1 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (angiogenin) | Trials (angiogenin) | Recent Studies (post-2010) (angiogenin) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 935 | 12 | 386 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christopoulou, G; Christoulas, D; Dimopoulos, MA; Gavriatopoulou, M; Gerofotis, A; Kastritis, E; Katodritou, E; Konstantinidou, P; Kourakli, A; Ntanasis-Stathopoulos, I; Symeonidis, A; Terpos, E; Zagouri, F | 1 |
1 trial(s) available for lenalidomide and angiogenin
| Article | Year |
|---|---|
Effect of induction therapy with lenalidomide, doxorubicin and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myeloma.
Topics: Adult; Aged; Alkaline Phosphatase; Angiogenic Proteins; Antineoplastic Combined Chemotherapy Protocols; Bone Resorption; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Female; Fibroblast Growth Factor 2; Gene Expression Regulation, Neoplastic; Humans; Induction Chemotherapy; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Osteocalcin; Peptide Fragments; Procollagen; Ribonuclease, Pancreatic; Treatment Outcome; Vascular Endothelial Growth Factor A | 2019 |